| Date | Time | Source | Headline | Symbol | Company |
| 10/30/2007 | 6:54AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/24/2007 | 7:54AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/24/2007 | 7:54AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/24/2007 | 7:54AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/23/2007 | 6:02AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/23/2007 | 6:02AM | Edgar (US Regulatory) | Novogen Ltd - Report of Foreign Issuer (6-K) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/03/2007 | 9:40AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 09/20/2007 | 3:59PM | Edgar (US Regulatory) | Novogen Ltd (Other) (SC 13D/A) | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/30/2007 | 8:30AM | PR Newswire (US) | A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/13/2007 | 9:41AM | PR Newswire (US) | Newly Published Research Indicates the Potential of Phenoxodiol to Protect Against Neuropathy | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/07/2007 | 9:00AM | PR Newswire (US) | Marshall Edwards, Inc. Raises US$16.4 Million in Private Equity Financing | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 08/06/2007 | 6:50PM | PR Newswire (US) | Marshall Edwards, Inc. Raises $16.4 Million in Private Equity Financing | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 07/30/2007 | 10:03AM | PR Newswire (US) | Investigational Anti-Inflammatory Drug Produces Promising Results in Animal Studies | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/26/2007 | 9:00AM | PR Newswire (US) | Novogen Reaches Settlement With Chattem on Isoflavone Patent Infringement Case | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/04/2007 | 12:21PM | PR Newswire (US) | Dr. Graham Kelly Retires as Director, Marshall Edwards, Inc. | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 06/01/2007 | 9:00AM | PR Newswire (US) | OVArian TUmor REsponse ('OVATURE') Trial Enrolls First U.S. Patient | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 05/04/2007 | 9:54AM | PR Newswire (US) | Novogen Frees Up Cash By Outsourcing Production for Consumer Products | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 05/01/2007 | 9:00AM | PR Newswire (US) | New Research Results Show That Investigational Drug Phenoxodiol Targets Cancer Protein, Causing Cancer Cell Death | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 04/04/2007 | 9:37AM | PR Newswire (US) | Marshall Edwards, Inc. Renegotiates Annual License Payments for Phenoxodiol | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 03/28/2007 | 11:24AM | PR Newswire (US) | New Board Appointment at Marshall Edwards, Inc. | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 02/27/2007 | 9:00AM | PR Newswire (US) | Novogen Subsidiary Glycotex, Inc., Receives Additional Funding | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/18/2007 | 4:06PM | PR Newswire (US) | Novogen & Sante Naturelle (Canada) Enter Into a Patent License Agreement and Settle Patent Infringement Case | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/08/2007 | 8:59AM | PR Newswire (US) | Marshall Edwards, Inc., Presentation at the 25th Annual JPMorgan Healthcare Conference to be Webcast. | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 01/04/2007 | 8:00AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at the 25th Annual JPMorgan Healthcare Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 12/12/2006 | 7:41PM | PR Newswire (US) | Marshall Edwards, Inc. Announces Initial Trial Sites, Principle Investigator for Phase III OVATURE Trial for Phenoxodiol | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 12/11/2006 | 9:19AM | PR Newswire (US) | Marshall Edwards' US Patent Advance for Phenoxodiol | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/28/2006 | 8:27AM | PR Newswire (US) | Marshall Edwards, Inc. Appoints Professor Bryan Williams as Chairman | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 11/27/2006 | 8:00AM | PR Newswire (US) | First Patient Treated in Phase III Ovarian Cancer Trial | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/30/2006 | 9:25AM | PR Newswire (US) | Marshall Edwards, Inc. has Appointed J.P. Morgan Securities Inc as Exclusive Financial Advisor | NASDAQ:KZIA | Kazia Therapeutics Ltd |
| 10/30/2006 | 9:09AM | PR Newswire (US) | Marshall Edwards, Inc. to Present at the Rodman & Renshaw 8th Annual Healthcare Conference | NASDAQ:KZIA | Kazia Therapeutics Ltd |